Pancreatic Cancer Research

ResearcherCornell UniversityActive in the last 2 years

Gina M. DeNicola

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6611-6696; OpenAlex author ID A5076253640. Sources: OpenAlex.

Their work

Papers
8 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
43
Papers, trials and grants by year

2012: 2 papers · 2013: none · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 8

  1. PHGDH is a targetable driver of PDAC progression Last author DOI 10.64898/2026.03.11.711147↗
  2. Mitochondrial Calcium Uniporter Drives Metastasis and Confers a Targetable Cystine Dependency in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-21-3230↗
  3. Coordinated Transcriptional and Catabolic Programs Support Iron-Dependent Adaptation to RAS-MAPK Pathway Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-22-0044↗
  4. Dynamic ROS Control by TIGAR Regulates the Initiation and Progression of Pancreatic Cancer. First author DOI 10.1016/j.ccell.2019.12.012↗
  5. Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-18-1409↗
  6. NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer. Co-author DOI 10.1016/j.cell.2016.06.056↗
  7. Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer. First author DOI 10.1038/onc.2011.350↗
  8. Cathepsin B promotes the progression of pancreatic ductal adenocarcinoma in mice. First author DOI 10.1136/gutjnl-2011-300850↗

Closest collaborators

The 25 strongest of 43 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yumi Kim · 1 shared paper, 2026 · strength 0.32
  2. H. Carlo Maurer · 1 shared paper, 2026 · strength 0.32
  3. Kenneth P. Olive · 1 shared paper, 2026 · strength 0.32
  4. David Arthur Tuveson · 5 shared papers, 2012–2020 · strength 0.31
  5. Karen H. Vousden · 2 shared papers, 2019–2020 · strength 0.20
  6. Shengyu Yang · 1 shared paper, 2022 · strength 0.13
  7. Liangliang Wu · 1 shared paper, 2022 · strength 0.13
  8. Chongbiao Huang · 1 shared paper, 2022 · strength 0.13
  9. Xiuchao Wang · 1 shared paper, 2022 · strength 0.13
  10. Pankaj Kumar Singh · 1 shared paper, 2022 · strength 0.13
  11. Jihui Hao · 1 shared paper, 2022 · strength 0.13
  12. Eric C. Cheung · 1 shared paper, 2020 · strength 0.13
  13. Anthony C. Venida · 1 shared paper, 2022 · strength 0.12
  14. Mirunalini Ravichandran · 1 shared paper, 2022 · strength 0.12
  15. Annan Yang · 1 shared paper, 2022 · strength 0.12
  16. Gilles Rademaker · 1 shared paper, 2022 · strength 0.12
  17. Andrew J. Aguirre · 1 shared paper, 2022 · strength 0.12
  18. Joseph Douglas Mancias · 1 shared paper, 2022 · strength 0.12
  19. Rushika Miriam Perera · 1 shared paper, 2022 · strength 0.12
  20. Youngkyu Park · 2 shared papers, 2016–2019 · strength 0.12
  21. Kay F. Macleod · 1 shared paper, 2019 · strength 0.08
  22. Brinda Alagesan · 1 shared paper, 2019 · strength 0.08
  23. Pedro Antonio Pérez-Mancera · 1 shared paper, 2019 · strength 0.08
  24. Timothy J. Humpton · 1 shared paper, 2019 · strength 0.08
  25. Carl-Stephan Leonhardt · 1 shared paper, 2019 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.